G01N 2333/70514
Cd4
G01N2333/70514 (Cd4) appears on 155 US grants and 303 published applications in this corpus.
Search patents in G01N- Granted patents
- 155
- Published applications
- 303
- Assignees
- 190
- Inventors
- 559
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 6 |
| 2005 | 1 | 3 |
| 2006 | 0 | 3 |
| 2007 | 0 | 6 |
| 2008 | 1 | 10 |
| 2009 | 2 | 12 |
| 2010 | 3 | 9 |
| 2011 | 5 | 15 |
| 2012 | 2 | 20 |
| 2013 | 4 | 8 |
| 2014 | 9 | 15 |
| 2015 | 6 | 24 |
| 2016 | 14 | 31 |
| 2017 | 8 | 14 |
| 2018 | 18 | 19 |
| 2019 | 11 | 12 |
| 2020 | 17 | 23 |
| 2021 | 11 | 10 |
| 2022 | 12 | 10 |
| 2023 | 6 | 17 |
| 2024 | 5 | 11 |
| 2025 | 12 | 14 |
| 2026 | 2 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Flow cytometry system and methods for the diagnosis of infectious disease3 Mar 2026US 12,566,176 B2FlowMetric Life Sciences, Inc.
- Method for labeling intracellular and extracellular targets of leukocytes27 Jan 2026US 12,535,482 B2Beckman Coulter, Inc.
- Cytometric assays28 Oct 2025US 12,455,286 B2The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center
- Peripheral blood biomarker for evaluating anti-tumor immune effect of radiation therapy14 Oct 2025US 12,442,820 B2Saitama Medical University
- CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs7 Oct 2025US 12,436,150 B2The Regents of the University of California
- Postural orthostatic tachycardia syndrome and crth224 Sep 2026US 2026/0287597 A1Amerimmune LLC
- Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy30 Jul 2026US 2026/0216331 A1Juno Therapeutics, Inc.
- Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy30 Jul 2026US 2026/0216332 A1Juno Therapeutics, Inc.
- Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy9 Jul 2026US 2026/0191959 A1Juno Therapeutics, Inc.
- Flow Cytometry System and Methods for the Diagnosis of Infectious Disease9 Jul 2026US 2026/0194521 A1FlowMetric Life Sciences, Inc.
Most cited
By later US patents
- Tolerogenic synthetic nanocarriers for inducing regulatory B cells129US 8,652,487 B2Selecta Biosciences, Inc. · 2014
- Assay implementation in a microfluidic format74US 7,553,453 B2Honeywell International Inc. · 2009
- Tolerogenic synthetic nanocarriers42US 9,265,815 B2Selecta Biosciences, Inc. · 2016
- Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins29US 9,295,718 B2Selecta Biosciences, Inc. · 2016
- Method for preventing HIV-1 infection of CD4+ cells28US 6,344,545 B12002